Labcorp Holdings Inc. has announced new agreements with Visby Medical and Quest to expand consumer access to the Visby Women’s Sexual Health Test, the first at-home, FDA-authorized PCR test for sexually transmitted infections. The collaboration will allow Labcorp to offer the Visby Rapid PCR At-Home Female STI Test through its Labcorp OnDemand digital platform. Additionally, Labcorp’s Ovia Health will make the test available to its employer and health plan partners in early 2026. The Visby test provides lab-accurate results for chlamydia, gonorrhea, and trichomoniasis in 30 minutes without the need to mail samples to a lab.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labcorp Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260108675059) on January 08, 2026, and is solely responsible for the information contained therein.